These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28666851)

  • 21. Aromatase induction in tamoxifen-resistant breast cancer: Role of phosphoinositide 3-kinase-dependent CREB activation.
    Phuong NT; Lim SC; Kim YM; Kang KW
    Cancer Lett; 2014 Aug; 351(1):91-9. PubMed ID: 24836190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells.
    Oh SJ; Kim O; Lee JS; Kim JA; Kim MR; Choi HS; Shim JH; Kang KW; Kim YC
    Food Chem Toxicol; 2010 Nov; 48(11):3227-34. PubMed ID: 20804812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.
    Kim J; Lee J; Kim C; Choi J; Kim A
    Tumour Biol; 2016 May; 37(5):5811-9. PubMed ID: 26581908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells.
    Gaballah AI; Elsherbiny AA; Sharaky M; Hamed NO; Raslan NA; Almilaibary A; Fayyad RMA; Ousman MS; Hamdan AME; Fahim SA
    Biosci Rep; 2024 Jul; 44(7):. PubMed ID: 38864530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM.
    Chen MJ; Cheng YM; Chen CC; Chen YC; Shen CJ
    Biochem Biophys Res Commun; 2017 Feb; 483(2):840-846. PubMed ID: 28063929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
    Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F
    Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells.
    Kim SK; Yang JW; Kim MR; Roh SH; Kim HG; Lee KY; Jeong HG; Kang KW
    Free Radic Biol Med; 2008 Aug; 45(4):537-46. PubMed ID: 18539158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
    Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
    Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
    Berstein LM; Yue W; Wang JP; Santen RJ
    Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells' response to tamoxifen].
    Cai Y; He J; Zhang D
    Mol Biol (Mosk); 2016; 50(5):821-827. PubMed ID: 27830684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of monocarboxylate transporter I/lactate dehydrogenase B-mediated lactate recycling in tamoxifen-resistant breast cancer cells.
    Choi MC; Kim SK; Choi YJ; Choi YJ; Kim S; Jegal KH; Lim SC; Kang KW
    Arch Pharm Res; 2023 Dec; 46(11-12):907-923. PubMed ID: 38048029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.
    Hawsawi Y; Humphries MP; Wright A; Berwick A; Shires M; Al-Kharobi H; El-Gendy R; Jove M; Twelves C; Speirs V; Beattie J
    Oncotarget; 2016 May; 7(22):32129-43. PubMed ID: 27050076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
    Ryu CS; Kwak HC; Lee JY; Oh SJ; Phuong NT; Kang KW; Kim SK
    Biochem Pharmacol; 2013 Jan; 85(2):197-206. PubMed ID: 23123664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy.
    Elias D; Vever H; Lænkholm AV; Gjerstorff MF; Yde CW; Lykkesfeldt AE; Ditzel HJ
    Oncogene; 2015 Apr; 34(15):1919-27. PubMed ID: 24882577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
    Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
    Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer.
    Liu B; Wang T; Wang H; Zhang L; Xu F; Fang R; Li L; Cai X; Wu Y; Zhang W; Ye L
    J Hematol Oncol; 2018 Feb; 11(1):26. PubMed ID: 29471853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells.
    Choi HK; Yang JW; Roh SH; Han CY; Kang KW
    Endocr Relat Cancer; 2007 Jun; 14(2):293-303. PubMed ID: 17639045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.
    Kumbrink J; Kirsch KH
    Neoplasia; 2012 Feb; 14(2):108-20. PubMed ID: 22431919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer.
    Bui QT; Im JH; Jeong SB; Kim YM; Lim SC; Kim B; Kang KW
    Cancer Lett; 2017 Apr; 390():115-125. PubMed ID: 28108315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional combination of resveratrol and tamoxifen to overcome tamoxifen-resistance in breast cancer cells.
    Radwan AM; Abosharaf HA; Sharaky M; Abdelmonem R; Effat H
    Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400261. PubMed ID: 38943449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.